Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,051.99
+29.972.93%
Post-market: 1,048.25-3.7400-0.36%19:59 EST
Volume:4.33M
Turnover:4.52B
Market Cap:994.53B
PE:45.84
High:1,053.00
Open:1,019.17
Low:1,017.36
Close:1,022.02
52wk High:1,133.95
52wk Low:623.78
Shares:945.38M
Float Shares:945.00M
Volume Ratio:1.36
T/O Rate:0.46%
Dividend:6.00
Dividend Rate:0.57%
EPS(TTM):22.95
EPS(LYR):22.95
ROE:101.16%
ROA:19.42%
PB:37.48
PE(LYR):45.84

Loading ...

Rothschild & Co Redburn Adjusts PT on Eli Lilly to $875 From $830, Maintains Neutral Rating

MT Newswires Live
·
Feb 23

Novo Nordisk's Obesity Drug Falls Short Against Eli Lilly's in Copenhagen Trial

Reuters
·
Feb 23

Eli Lilly Shares Rise 2.1% Premarket After Novo Nordisk's Obesity Drug Falls Short Against Eli Lilly's in Copenhagen Trial

THOMSON REUTERS
·
Feb 23

Ratings Weekly | Nvidia, Apple, Microsoft, Amazon, Netflix, Palantir, Broadcom, CoreWeave, Carvana and More to Watch

Tiger Newspress
·
Feb 22

Bridgewater Associates' 4Q Buying and Selling -- Barron's

Dow Jones
·
Feb 21

Eli Lilly & Co. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Feb 21

Top Calls on Wall Street: Apple, Microsoft, Netflix, Broadcom, CoreWeave, Eli Lilly, Walmart, and More

Tiger Newspress
·
Feb 20

Eli Lilly Initiated at Overweight by Barclays

Dow Jones
·
Feb 20

Eli Lilly Stock (LLY) Rises as Company Reports Progress with Crohn’s Disease Treatment

TIPRANKS
·
Feb 20

Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions

Reuters
·
Feb 20

Eli Lilly initiated with an Overweight at Barclays

TIPRANKS
·
Feb 20

Eli Lilly announces long-term data on Omvoh in Crohn’s disease

TIPRANKS
·
Feb 20

Lilly Says Omvoh Maintains Steroid-Free Remission for Three Years in Crohn’s Disease Patients

Reuters
·
Feb 20

Eli Lilly - Over 90% Maintained Steroid-Free Control Through Three Years

THOMSON REUTERS
·
Feb 20

Eli Lilly Pushes Into Opioid Use Disorder With New Brenipatide Phase 2 Trial

TIPRANKS
·
Feb 20

Berenberg Adjusts Price Target on Eli Lilly to $1,050 From $950, Maintains Hold Rating

MT Newswires Live
·
Feb 19

Three multinationals pay almost half of all Irish corporate tax, watchdog says

Reuters
·
Feb 19

U.S. RESEARCH ROUNDUP-EBay, Huntsman, Palo Alto

Reuters
·
Feb 19

Eli Lilly : Berenberg Raises Target Price to $1050 From $950

THOMSON REUTERS
·
Feb 19

Eli Lilly Stock (LLY) in Focus as Zepbound Found to Help Treat Psoriasis

TIPRANKS
·
Feb 18